Your session is about to expire
← Back to Search
Behavioural Intervention
Dynamic Lighting for Dementia
N/A
Waitlist Available
Led By NASTARAN SHISHEGAR, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours everyday during the last 7 days of each condition, namely 7 days of baseline, 7 days of dynamic, and 7 days of placebo.
Awards & highlights
Study Summary
This trial tests the effect of a special light intervention on sleep, circadian activity and moods of elderly people with dementia in long-term care.
Who is the study for?
This trial is for older adults over 50 with mild to major dementia who are not currently using light therapy or light-altering devices. They should have no major organ failure, significant additional diagnoses, history of head injury, obstructing cataracts, macular degeneration, or blindness.Check my eligibility
What is being tested?
The study tests dynamic lighting that changes intensity and spectrum throughout the day against placebo lighting in long-term care facilities. It aims to see if this can improve sleep quality, circadian rhythms, and mood in older adults with dementia.See study design
What are the potential side effects?
Since this trial involves lighting interventions rather than medication or invasive procedures, side effects may be minimal but could include discomfort due to changes in light exposure or potential disruption of usual sleep patterns.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours everyday during the last 7 days of each condition, namely 7 days of baseline, 7 days of dynamic, and 7 days of placebo.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours everyday during the last 7 days of each condition, namely 7 days of baseline, 7 days of dynamic, and 7 days of placebo.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Nocturnal Sleep Duration (in minutes) as measured by actigraphy
Change in Percent Sleep Efficiency (total sleep time divided by time in bed) measured by actigraphy.
Changes in agitation levels measured by Cohen-Mansfield Agitation Inventory (CMAI).
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Placebo Condition followed by Dynamic ConditionExperimental Treatment2 Interventions
Each lighting condition will last for three weeks (Weeks 2-4 or 5-7). The order of conditions will be randomized. Sleep data will be collected only on the last 7 days of each condition using actigraphy. Light spectrum and intensity will be tracked continuously throughout the waking hours (wearable light tracker). Moreover, caregivers will complete two questionnaires (CSDD and CMAI) every seven days to assess the short and long-term effects of each condition on mood and agitation of older adult participants.
Group II: Dynamic Condition followed by Placebo ConditionExperimental Treatment2 Interventions
Each lighting condition will last for three weeks (Weeks 2-4 or 5-7). The order of conditions will be randomized. Sleep data will be collected only on the last 7 days of each condition using actigraphy. Light spectrum and intensity will be tracked continuously throughout the waking hours (wearable light tracker). Moreover, caregivers will complete two questionnaires (CSDD and CMAI) every seven days to assess the short and long-term effects of each condition on mood and agitation of older adult participants.
Find a Location
Who is running the clinical trial?
Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
109,504 Total Patients Enrolled
5 Trials studying Sleep
284 Patients Enrolled for Sleep
Arizona Alzheimer's ConsortiumUNKNOWN
Arizona State University Knowledge EnterpriseUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are older than 50 years.You have been diagnosed with any level of dementia as determined by your doctor and care facility manager.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo Condition followed by Dynamic Condition
- Group 2: Dynamic Condition followed by Placebo Condition
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still availability for participants to join the experiment?
"This research project, posted on the 13th of January and modified two days later, is in need of participants as indicated by clinicaltrials.gov."
Answered by AI
How many total participants are allowed in this clinical trial?
"Affirmative. According to the details provided on clinicaltrials.gov, this scientific venture is currently in search of volunteers; it was initially posted on January 13th 2023 and last modified on January 15th 2023. It requires a total of 30 participants from 3 study sites."
Answered by AI
Share this study with friends
Copy Link
Messenger